Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$135,264,405
-$16,747,347 QoQ
Shares Held
3,170,755
+0.5% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#16
of 713 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Derivatives in SNY
reported options exposure · as of Jun 30, 2023CallValue
$21,306,670
CallShares
395,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $19,128,320,487 across 19 Drug Manufacturers - General names. SNY ranks #13 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,358,401 | $5,227,597,337 | |
| 2 | JNJ |
Johnson & Johnson
|
13,211,475 | $3,355,318,297 | |
| 3 | ABBV |
AbbVie Inc.
|
8,163,806 | $2,054,340,133 | |
| 4 | AZN |
Astrazeneca PLC
|
10,427,503 | $1,977,263,112 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,293,086 | $1,836,661,547 | |
| 6 | AMGN |
Amgen Inc
|
4,328,785 | $1,567,539,618 | |
| 7 | PFE |
Pfizer Inc
|
32,814,260 | $790,167,373 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,094,886 | $696,907,326 |
All Filings in SNY
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $135,264,405 | 3,170,755 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $152,011,752 | 3,155,080 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $130,076,229 | 2,684,198 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $154,639,186 | 3,276,254 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $156,418,162 | 3,237,801 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $134,917,595 | 2,432,701 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $115,389,692 | 2,392,488 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $140,847,660 | 2,443,999 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $121,620,614 | 2,506,608 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $109,839,108 | 2,260,064 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $100,162,532 | 2,014,127 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $112,810,977 | 2,103,113 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $114,564,448 | 2,125,500 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $21,306,670 | 395,300 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $112,435,851 | 2,066,076 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $83,209,128 | 1,718,132 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $67,746,846 | 1,781,874 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $91,822,156 | 1,835,342 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $94,487,108 | 1,840,419 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $81,504,280 | 1,626,832 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $78,269,797 | 1,623,518 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $81,752,432 | 1,552,458 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $73,905,303 | 1,494,244 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $72,645,300 | 1,495,067 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $74,604,992 | 1,487,044 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $76,640,289 | 1,501,279 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,062,396 | 24,300 | Call | Defined | 2020-06-16 | |
| 2020-03-31 | $62,960,294 | 1,440,080 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||